Short report: Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 4, 2010, Pages 822-824

  Turgay, Nevin ^a   Balcioglu, I Cuneyt ^b   Toz, Seray Ozensoy ^a   Ozbel, Yusuf ^a   Jones, Stephen L ^c  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c Cellestis Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LEISHMANIAL ANTIGEN; PARASITE ANTIGEN; UNCLASSIFIED DRUG; LEISHMANIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST; HUMAN; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; QUANTIFERON ASSAY; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; BLOOD; IMMUNOLOGY; LEISHMANIA; SECRETION; SEROLOGY;

LEISHMANIA INFANTUM; LEISHMANIA MAJOR;

ANTIGENS, PROTOZOAN; HUMANS; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; T-LYMPHOCYTES;

EID: 79955833683     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0605     Document Type: Article

References (9)

1. Sadeghian G, Momeni A, Siadat AH, Usefi P, 2006. Evaluation of leishmanin skin test and its relationship with the clinical form and duration of cutaneous leishmaniasis. Dermatol Online J 12: 3.
2. Bern C, Amann J, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, Wagatsuma Y, Breiman RF, Secor WE, Maguire JH, 2006. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. Am J Trop Med Hyg 75: 744-748. (Pubitemid 46941287)
3. Herwaldt BL, 1999. Leishmaniasis. Lancet 354: 1191-1199. (Pubitemid 29460458)
4. Gidwani K, Rai M, Chakravarty J, Boelaert M, Sundar S, 2009. Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med Hyg 80: 566-567.
5. Dheda K, Smit RZ, Badri M, Pai M, 2009. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 15: 188-200.
6. Katial RK, Hershey J, Purohit-Seth T, Belisle JT, Brennan PJ, Spencer JS, Engler RJ, 2001. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in wholeblood culture. Clin Diagn Lab Immunol 8: 339-345. (Pubitemid 32217065)
7. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS, 2001. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286: 1740-1747. (Pubitemid 33010260)
8. Mol CJ, Koethe SM, 2006. QuantiFERON TB GOLD: an innovation in tuberculosis screening. AAOHN J 54: 245-247.
9. Ehlers S, Smith KA, 1991. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 173: 25-36.